Patents by Inventor C. Daniel Meyers

C. Daniel Meyers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF LIVER DISEASE OR DISORDER COMPRISING ACTRII RECEPTOR ANTAGONISTS
    Publication number: 20220340668
    Abstract: The present disclosure provides an ActRII antagonist, e.g., the ActRIIA and/or ActRIIB antagonist, e.g., an anti-ActRII receptor antibody or antigen-binding fragment thereof, e.g., bimagrumab, for treating or preventing liver disease or disorder in a subject in need thereof. The present disclosure also relates to pharmaceutical combinations comprising such ActRII antagonists and at least one further therapeutic agent in the treatment or prevention of liver disease or disorder.
    Type: Application
    Filed: September 1, 2020
    Publication date: October 27, 2022
    Inventors: Laura COLEMAN, C. Daniel MEYERS, Ronenn ROUBENOFF, Estelle TRIFILIEFF
  • Licofligozin for the treatment of non-alcoholic steatohepatitis
    Patent number: 11179364
    Abstract: The disclosure concerns the use of LIK066 in the treatment, prevention or delay of non-alcoholic steatohepatitis.
    Type: Grant
    Filed: June 20, 2018
    Date of Patent: November 23, 2021
    Assignee: Novartis AG
    Inventors: Lloyd Klickstein, C. Daniel Meyers, Chinweike Ukomadu
  • LICOFLIGOZIN FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS
    Publication number: 20210145794
    Abstract: The disclosure concerns the use of LIK066 in the treatment, prevention or delay of non-alcoholic steatohepatitis.
    Type: Application
    Filed: June 20, 2018
    Publication date: May 20, 2021
    Inventors: Lloyd Klickstein, C. Daniel Meyers, Chinweike Ukomadu